All
Dato-DXd Plus Imfinzi Benefits Patients with Lung Cancer
September 13th 2023The TROPION-Lung04 trial reveals improvements from combining Dato-DXd with Imfinzi with or without carboplatin for patients with previously untreated advanced or metastatic non-small cell lung cancer (NSCLC) without actionable genomic alterations.